BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23248153)

  • 1. Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series.
    Mahfoud F; Böhm M; Rump LC; Vonend O; Schmieder RE; Kintscher U
    Hypertension; 2013 Feb; 61(2):e17. PubMed ID: 23248153
    [No Abstract]   [Full Text] [Related]  

  • 2. Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients.
    Vink EE; Blankestijn PJ
    Hypertension; 2013 Feb; 61(2):e8. PubMed ID: 23213193
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to- control hypertensive patients: prospective case series.
    Jordan J; Heusser K; Brinkmann J; Schmidt B; Menne J; Klein G; Bauersachs J; Haller H; Sweep FC; Diedrich A; Tank J
    Hypertension; 2013 Feb; 61(2):e18. PubMed ID: 23444462
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to- control hypertensive patients.
    Heusser H; Tank J; Brinkmann J; Schmidt B; Menne J; Klein G; Bauersachs J; Haller H; Sweep FC; Diedrich A; Jordan J
    Hypertension; 2013 Feb; 61(2):e9-10. PubMed ID: 23444459
    [No Abstract]   [Full Text] [Related]  

  • 5. Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series.
    Brinkmann J; Heusser K; Schmidt BM; Menne J; Klein G; Bauersachs J; Haller H; Sweep FC; Diedrich A; Jordan J; Tank J
    Hypertension; 2012 Dec; 60(6):1485-90. PubMed ID: 23045466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure and sympathetic nervous system response to renal denervation.
    Schlaich M; Hering D; Lambert G; Lambert E; Esler M
    Hypertension; 2013 Feb; 61(2):e13. PubMed ID: 23248152
    [No Abstract]   [Full Text] [Related]  

  • 7. Future of catheter-based renal denervation: key issues to solve.
    Kimura G
    Hypertens Res; 2013 Jun; 36(6):492-3. PubMed ID: 23595049
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to Wang et al.: Mechanisms for catheter-based renal denervation to lower blood pressure: personal speculation.
    Kimura G
    Hypertens Res; 2013 Nov; 36(11):1008. PubMed ID: 24067891
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to blood pressure and sympathetic nervous system response to renal denervation.
    Heusser K; Tank J; Brinkmann J; Schmidt B; Menne J; Klein G; Bauersachs J; Haller H; Sweep FC; Diedrich A; Jordan J
    Hypertension; 2013 Feb; 61(2):e14. PubMed ID: 23444460
    [No Abstract]   [Full Text] [Related]  

  • 10. Control of salt and volume retention cannot be ruled out as a mechanism underlying the blood pressure-lowering effect of renal denervation.
    Wang Y; Denton KM; Golledge J
    Hypertens Res; 2013 Nov; 36(11):1006-7. PubMed ID: 23945966
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal nerve ablation for resistant hypertension: how did we get here, present status, and future directions.
    Papademetriou V; Rashidi AA; Tsioufis C; Doumas M
    Circulation; 2014 Apr; 129(13):1440-51. PubMed ID: 24687645
    [No Abstract]   [Full Text] [Related]  

  • 12. Spike rate of multi-unit muscle sympathetic nerve fibers after catheter-based renal nerve ablation.
    Tank J; Heusser K; Brinkmann J; Schmidt BM; Menne J; Bauersachs J; Haller H; Diedrich A; Jordan J
    J Am Soc Hypertens; 2015 Oct; 9(10):794-801. PubMed ID: 26324745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can physiology zap therapeutic sweet spots in hypertension?
    Joyner MJ
    Hypertension; 2012 Dec; 60(6):1385-6. PubMed ID: 23045467
    [No Abstract]   [Full Text] [Related]  

  • 14. Cochrane corner: renal denervation for resistant hypertension-a broken promise?
    Bolignano D; Coppolino G
    Heart; 2017 Nov; 103(22):1753-1755. PubMed ID: 28501794
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal denervation for human hypertension: is there a future?
    Izzo JL; Tobe SW
    J Am Soc Hypertens; 2016 May; 10(5):390-2. PubMed ID: 27049792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the indication spectrum: renal denervation in diabetes.
    Mahfoud F; Ewen S; Ukena C; Linz D; Sobotka PA; Cremers B; Böhm M
    EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future for renal denervation depends on embracing the lessons learned from our previous studies.
    Epstein M
    J Am Soc Hypertens; 2016 May; 10(5):396-8. PubMed ID: 27079956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Denervation-Ready for Prime Time!? The Steep SPYRAL Stairs to RADIANCE in Hypertension Treatment.
    Schlaich MP; Kiuchi MG; Esler MD
    Hypertension; 2018 Aug; 72(2):287-290. PubMed ID: 29941510
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal denervation: should we still hang in there?
    Hao Y; Lu Z
    Int J Cardiol; 2014 Oct; 176(3):1255-6. PubMed ID: 25129307
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal sympathetic denervation for the treatment of systemic hypertension.
    Burke GM; Sica DA; Frishman WH
    Cardiol Rev; 2012; 20(6):274-8. PubMed ID: 22717655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.